Main Street Capital Corporation vs Smith & Nephew plc — how do they compare? Main Street Capital Corporation trades at $59 (market cap $5.52B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 2.3× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays the higher dividend (5.39%). Which is the better fit depends on your goals.
| MAIN | SNN | |
|---|---|---|
Market Cap | $5.52B | $12.54B |
Sector | Financials | Health |
52-Week High | $67.54 | $38.70 |
52-Week Low | $49.63 | $28.73 |
Dividend Yield | 5.39% | 2.65% |
Enterprise Value | — | $15.57B |
Trailing returns across standard periods
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →